| CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 |
Globe Newswire |
06/06 |
16:00 |
| HERE Technologies appoints Denise Doyle as Chief Product Officer |
Globe Newswire |
06/06 |
16:00 |
| Resilinc Appoints Sumit Vakil as First Chief Artificial Intelligence Officer |
Globe Newswire |
06/06 |
16:00 |
| ViaDerma Provides Highlights of Quarterly Financial Report |
Globe Newswire |
06/06 |
16:00 |
| Bitdeer Announces Acquisition of Desiweminer in an All-Stock Transaction |
Globe Newswire |
06/06 |
16:00 |
| Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress |
Globe Newswire |
06/06 |
16:00 |
| Tide Capital: BTC Sees Volatile Upsurge, Meme Coins Start New Upward Cycle |
Globe Newswire |
06/06 |
16:00 |
| Quantexa Announces Partnership with Databricks to Help Customers Rapidly Scale Data and AI Initiatives |
Globe Newswire |
06/06 |
16:00 |
| Zscaler to Host Innovations Briefing for Investors at Zenith Live 2024 |
Globe Newswire |
06/06 |
16:00 |
| Understanding the AI in Manufacturing Market: Regional Insights, Applications, and Leading Companies |
Globe Newswire |
06/06 |
16:00 |
| Genius Group Announces Updated Investor Presentation and Compliance with NYSE Guidelines on Audit Opinion |
Globe Newswire |
06/06 |
16:00 |
| Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 |
Globe Newswire |
06/06 |
16:00 |
| Rodedawg (OTC: RWGI) Expands into Dispensary Acquisitions and Signs Letter of Intent for Dispensary License |
Globe Newswire |
06/06 |
16:00 |
| Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June |
Globe Newswire |
06/06 |
15:57 |
| Unlocking Potential: Furrever Token’s 25% Bonus Amid Bitcoin and Ethereum’s Success |
Globe Newswire |
06/06 |
15:32 |
| Vishay Intertechnology Expands Resistor Product Portfolio |
Globe Newswire |
06/06 |
15:30 |
| Research Frontiers and AIT Group Unveil Revolutionary Retrofittable SPD-SmartGlass Window At AIA Conference on Architecture & Design in Washington DC |
Globe Newswire |
06/06 |
15:30 |
| Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients |
Globe Newswire |
06/06 |
15:30 |
| 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference |
Globe Newswire |
06/06 |
15:30 |
| Venus Concept Regains Compliance with Nasdaq’s Minimum Equity Requirement |
Globe Newswire |
06/06 |
15:30 |
| Standard Uranium Intersects Local Anomalous Radioactivity and Hydrothermal Alteration at Canary Project; Concludes Inaugural Drill Program |
Globe Newswire |
06/06 |
15:30 |
| Bombardier Defense and ADAC Announce Order of a new Challenger 650 Aircraft for Medevac Use |
Globe Newswire |
06/06 |
15:30 |
| Orion’s Q4’24 Revenue Rose 22% to $26.4M; FY’24 Revenue of $90.6M Driven by Growth Across LED Lighting, EV Charging and Maintenance Businesses; Targets FY 2025 Revenue Growth of 10-15% |
Globe Newswire |
06/06 |
15:29 |
| B2Gold and Sandbox Royalties Partner to Create Versamet Royalties; B2Gold Receives $90 Million Equity Interest in Versamet |
Globe Newswire |
06/06 |
15:00 |
| Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma |
Globe Newswire |
06/06 |
15:00 |
